NYMOX PHARMACEUTICAL CORPORATION Description Of Risk Free Interest Rate Share Options Granted
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Description Of Risk Free Interest Rate Share Options Granted of 0.00% for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted · last filed 2025-06-03
| Period end | Description Of Risk Free Interest Rate Share Options Granted 12 month |
|---|---|
| 2024-12-31 | 0.00% 20-F · filed 2025-06-03 |
| 2019-12-31 | 2.48% 20-F · filed 2022-03-30 |
| 2017-12-31 | 2.38% 20-F · filed 2020-03-30 |
| 2015-12-31 | 1.41% 20-F · filed 2018-03-30 |